CTRI/2017/07/009130
Completed
未知
A descriptive study to assess the immunization compliance, common health problems of immunized under five children and perceived maternal barriers for immunization in selected rural areas of Udupi district.
I0 sites310 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- I
- Enrollment
- 310
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Mothers who have children less than five years of age, mothers who have immunization card of their children, mothers who have registered in the primary health care centers and Anganwadi of Udupi district and mothers who can read and understand kannada
Exclusion Criteria
- •Mothers who are not having the immunization card of their children, who are not able to read and understand kannada, and are not available during the time of data collection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressantsPatients under treatment of immunosuppressants (CsA, FK, MZR, NNF, AZP)JPRN-UMIN000007710Department of Nephrology and Rheumatology National Center for Child Health and Development200
Completed
Not Applicable
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
Completed
Not Applicable
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60
Active, not recruiting
Phase 1
A Study of Safety and Clinical Activity of Cancer Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsPatients with unresectable and progressive metastatic cutaneous melanoma, whose tumor expresses MAGE-A3.MedDRA version: 16.0Level: LLTClassification code 10027481Term: Metastatic melanomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2008-001918-25-BEGlaxoSmithKline Biologicals40
Active, not recruiting
Phase 1
A Study of Safety and Clinical Activity of Cancer Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsEUCTR2008-001918-25-FRGlaxoSmithKline Biologicals48